Further research is needed to investigate the effectiveness of combining low-dose IL-2 with standard immunosuppressive medications, such as mycophenolate mofetil or hydroxychloroquine, in order to identify the most effective treatment methods for patients with systemic lupus erythematosus (SLE) [15]. This evidence concerns the gene IL2 and systemic lupus erythematosus.